HOME / PUBLICATIONS /

Implications of thymidylate synthase gene polymorphisms, KRAS and BRAF mutations in the survival of patients with colorectal cancer treated with adjuvant chemotherapy

Citation:

Ntavatzikos A, Spathis A, Patapis P, Peros G, Panayiotides I, Papadopoulos I, Koumarianou A. Implications of thymidylate synthase gene polymorphisms, KRAS and BRAF mutations in the survival of patients with colorectal cancer treated with adjuvant chemotherapy. Annals of Oncology. 2018;29:viii176.